BayMedica, LLC is a subsidiary of InMed Pharmaceuticals, specializing in the large-scale production of rare cannabinoids. Using cutting-edge biosynthesis and synthetic chemistry, BayMedica provides nature-identical cannabinoids, such as CBC, THCV, CBDV, and CBT. Their cannabinoids are used in various industries, including pharmaceuticals, nutraceuticals, cosmetics, and animal health. BayMedica's proprietary production platform ensures scalable, pure, and environmentally sustainable cannabinoid solutions for a wide range of applications. Their innovative approach avoids traditional plant cultivation, focusing instead on advanced bioreactor systems.